105 related articles for article (PubMed ID: 17912455)
1. N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.
Saiko P; Ozsvar-Kozma M; Bernhaus A; Jaschke M; Graser G; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Int J Oncol; 2007 Nov; 31(5):1261-6. PubMed ID: 17912455
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
Horvath Z; Murias M; Saiko P; Erker T; Handler N; Madlener S; Jaeger W; Grusch M; Fritzer-Szekeres M; Krupitza G; Szekeres T
Exp Hematol; 2006 Oct; 34(10):1377-84. PubMed ID: 16982330
[TBL] [Abstract][Full Text] [Related]
3. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Exp Hematol; 2005 Mar; 33(3):329-35. PubMed ID: 15730856
[TBL] [Abstract][Full Text] [Related]
4. Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity.
Saiko P; Pemberger M; Horvath Z; Savinc I; Grusch M; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Oncol Rep; 2008 Jun; 19(6):1621-6. PubMed ID: 18497974
[TBL] [Abstract][Full Text] [Related]
5. A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
Saiko P; Graser G; Giessrigl B; Lackner A; Grusch M; Krupitza G; Basu A; Sinha BN; Jayaprakash V; Jaeger W; Fritzer-Szekeres M; Szekeres T
Biochem Pharmacol; 2011 Jan; 81(1):50-9. PubMed ID: 20849828
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1019-24. PubMed ID: 17065057
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.
Saiko P; Horvath Z; Murias M; Handler N; Jaeger W; Erker T; Fritzer-Szekeres M; Szekeres T
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1013-7. PubMed ID: 17065056
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
Bernhaus A; Ozsvar-Kozma M; Saiko P; Jaschke M; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Invest New Drugs; 2009 Oct; 27(5):393-401. PubMed ID: 18841326
[TBL] [Abstract][Full Text] [Related]
10. Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Fritzer-Szekeres M; Szekeres T
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1541-4. PubMed ID: 15571294
[TBL] [Abstract][Full Text] [Related]
11. Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.
Fritzer-Szekeres M; Savinc I; Horvath Z; Saiko P; Pemberger M; Graser G; Bernhaus A; Ozsvar-Kozma M; Grusch M; Jaeger W; Szekeres T
Int J Oncol; 2008 Oct; 33(4):887-92. PubMed ID: 18813804
[TBL] [Abstract][Full Text] [Related]
12. Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells.
Saiko P; Ozsvar-Kozma M; Madlener S; Bernhaus A; Lackner A; Grusch M; Horvath Z; Krupitza G; Jaeger W; Ammer K; Fritzer-Szekeres M; Szekeres T
Cancer Lett; 2007 Jun; 250(2):323-8. PubMed ID: 17137710
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine.
Saiko P; Steinmann MT; Schuster H; Graser G; Bressler S; Giessrigl B; Lackner A; Grusch M; Krupitza G; Bago-Horvath Z; Jaeger W; Fritzer-Szekeres M; Szekeres T
Phytomedicine; 2015 Jan; 22(1):213-22. PubMed ID: 25636891
[TBL] [Abstract][Full Text] [Related]
14. Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosine.
Graser-Loescher G; Schoenhuber A; Ciglenec C; Eberl S; Krupitza G; Mader RM; Jadav SS; Jayaprakash V; Fritzer-Szekeres M; Szekeres T; Saiko P
Food Chem Toxicol; 2017 Oct; 108(Pt A):53-62. PubMed ID: 28716444
[TBL] [Abstract][Full Text] [Related]
15. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
[TBL] [Abstract][Full Text] [Related]
16. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.
Madlener S; Illmer C; Horvath Z; Saiko P; Losert A; Herbacek I; Grusch M; Elford HL; Krupitza G; Bernhaus A; Fritzer-Szekeres M; Szekeres T
Cancer Lett; 2007 Jan; 245(1-2):156-62. PubMed ID: 16488533
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells.
Meli M; Tolomeo M; Grifantini M; Mai A; Cappellacci L; Petrelli R; Rotili D; Ferro A; Saiko P; Szekeres T; Dusonchet L
Int J Oncol; 2011 May; 38(5):1427-36. PubMed ID: 21318222
[TBL] [Abstract][Full Text] [Related]
18. Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.
Höchtl T; Horvath Z; Bauer W; Karl D; Saiko P; Elford HL; Fritzer-Szekeres M; Szekeres T
Life Sci; 2004 Jan; 74(9):1071-80. PubMed ID: 14687648
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
[TBL] [Abstract][Full Text] [Related]
20. Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells.
Bernhaus A; Fritzer-Szekeres M; Grusch M; Saiko P; Krupitza G; Venkateswarlu S; Trimurtulu G; Jaeger W; Szekeres T
Cancer Lett; 2009 Feb; 274(2):299-304. PubMed ID: 18952370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
